Company Filing History:
Years Active: 1998-2014
Title: Katsuiku Hirokawa: Innovator in Immunity Evaluation and Metabolic Bone Diseases
Introduction
Katsuiku Hirokawa is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of immunology and metabolic bone diseases. With a total of 2 patents, his work has the potential to impact medical diagnostics and treatment.
Latest Patents
Hirokawa's latest patents include an immunity evaluation method, an immunity evaluation apparatus, and an immunity evaluation program. The immunity evaluation method focuses on assessing immunity by utilizing immune cell markers found in sampled blood. This method involves determining evaluation values for selected immune cell markers, adding these values, and ultimately evaluating immunity based on the results. Additionally, he has developed transgenic mice as a model for metabolic bone diseases. These mice carry a recombinant DNA construct that includes the gene for diphtheria toxin A chain linked to an osteocalcin promoter, making them valuable for studying conditions associated with decreased bone mass.
Career Highlights
Throughout his career, Hirokawa has worked with notable institutions such as Tokyo Medical and Dental University and Hoechst Japan Limited. His research has contributed to advancements in understanding immune responses and bone health.
Collaborations
Hirokawa has collaborated with esteemed colleagues, including Masanori Utsuyama and Masanobu Kitagawa. These partnerships have fostered innovation and enhanced the impact of his research.
Conclusion
Katsuiku Hirokawa's work in immunity evaluation and metabolic bone diseases showcases his dedication to advancing medical science. His innovative patents and collaborations highlight his role as a key figure in the field.